Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 8.36B | 8.17B | 7.42B | 8.22B | 7.50B | 6.13B |
Gross Profit | 2.03B | 1.98B | 1.78B | 2.09B | 1.55B | 1.04B |
EBITDA | 1.29B | 1.25B | 1.12B | 1.48B | 919.52M | 509.18M |
Net Income | 906.50M | 883.31M | 768.93M | 1.05B | 663.03M | 243.44M |
Balance Sheet | ||||||
Total Assets | 9.38B | 9.30B | 8.67B | 8.47B | 8.73B | 7.74B |
Cash, Cash Equivalents and Short-Term Investments | 377.81M | 487.15M | 798.57M | 725.58M | 834.93M | 538.14M |
Total Debt | 2.16B | 2.20B | 2.10B | 2.58B | 3.40B | 3.01B |
Total Liabilities | 3.43B | 3.42B | 3.34B | 3.82B | 4.76B | 4.14B |
Stockholders Equity | 5.95B | 5.87B | 5.31B | 4.63B | 3.93B | 3.50B |
Cash Flow | ||||||
Free Cash Flow | 387.48M | 173.75M | 772.74M | 1.08B | 355.45M | 1.09B |
Operating Cash Flow | 423.21M | 210.08M | 806.17M | 1.11B | 376.65M | 1.12B |
Investing Cash Flow | -153.66M | -136.44M | -97.19M | -14.88M | -74.26M | -312.80M |
Financing Cash Flow | -448.84M | -393.57M | -628.51M | -1.20B | -155.00K | -604.94M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $10.93B | 8.40 | 18.09% | 0.90% | 1.59% | -8.04% | |
80 Outperform | $20.76B | 7.44 | 25.52% | 0.85% | 8.86% | 13.60% | |
77 Outperform | $6.03B | 6.98 | 15.97% | ― | 12.19% | 23.15% | |
76 Outperform | $21.03B | 14.98 | 38.25% | ― | 8.81% | 1.79% | |
73 Outperform | $28.78B | 9.23 | 13.06% | 1.82% | -1.20% | -17.61% | |
73 Outperform | $4.72B | 6.84 | 14.58% | 2.62% | -0.68% | -7.99% | |
66 Neutral | S$875.58M | 33.05 | 6.05% | 4.27% | 6.06% | -31.90% |
On May 22, 2025, Taylor Morrison Home Corporation held its 2025 Annual Meeting of stockholders, where nine directors were elected to serve until the 2026 meeting. Additionally, stockholders approved the executive compensation plan and ratified Deloitte & Touche LLP as the independent auditor for the fiscal year ending December 31, 2025. These decisions are expected to impact the company’s governance and financial oversight positively.
The most recent analyst rating on (TMHC) stock is a Buy with a $88.00 price target. To see the full list of analyst forecasts on Taylor Morrison stock, see the TMHC Stock Forecast page.